Bank Of America Corp Acelrx Pharmaceuticals Inc Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.28 - $0.61 $514 - $1,121	-1,838 Reduced 99.78%	4 $0
Q4 2021 Feb 08, 2022	SELL	$0.49 - $1.02 $215,655 - $448,916	-440,114 Reduced 99.58%	1,842 $1,000
Q3 2021 Nov 15, 2021	BUY	$0.93 - $1.51 $77,027 - $125,065	82,825 Added 23.06%	441,956 $450,000
Q2 2021 Sep 13, 2021	BUY	$1.03 - $1.7 $369,904 - $610,522	359,131 New	359,131 $496,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.